Page 300 - 2021 IDMT Digital
P. 300
HYPERTHYROIDISM
Introduction:
• +\SHUWK\URLGLVP RFFXUV ZKHQ WKHUH LV H[FHVV WK\URLG KRUPRQH FLUFXODWLQJ LQ WKH EORRG
• 7KH PRVW FRPPRQ FDXVH RI WKLV SUREOHP LV *UDYHV' GLVHDVH ZKLFK LV DQ DXWRLPPXQH
GLVRUGHU
• 7K\URLG VWRUP LV D YDULDWLRQ RI K\SHUWK\URLGLVP ZLWK VHYHUH V\PSWRPV SRWHQWLDOO\ OHDGLQJ
WR FRPD and death from cardiovascular collapse
Subjective:
• 6LJQV DQG 6\PSWRPV
o 1HUYRXVQHVV
o +HDW LQWROHUDQFH
o :HLJKW ORVV
o 'LDUUKHD
• )RFXVHG +LVWRU\
o )DPLO\ KLVWRU\ RI WK\URLG GLVHDVH
o (UHFWLOH G\VIXQFWLRQ
o 'HFUHDVHG OLELGR
Objective:
• 3K\VLFDO ([DP
o 9LWDO VLJQV mD\ EH WDFK\FDUGLF ZLWK DQ DUUK\WKPLD
o 8SSHU H\H OLG UHWUDFWLRQ
o /LG ODJ
o ([RSWKDOPRV "EXJ-H\Hd"
o )LQH WUHPRU RI WKH KDQGV
o +\SHUUHIOH[LD
o 'LIIXVHO\ HQODUJHG WK\URLG
• 7RROV
o Thyroid function tests (TSH/free T4); cRQVLGHU (.* LI DUUK\WKPLD QRWHG
Assessment:
• 'LIIHUHQWLDO
o +\SRWK\URLGLVP EUDG\FDUGLD ZHLJKW JDLQ
o $GUHQDO GLVHDVH VNLQ WDQQLQJ K\SRWHQVLRQ ZHLJKW ORVV
o 'LDEHWHV RIWHQ FR H[LVWV ZLWK WK\URLG GLVHDVH
o 2UELWDO WXPRU LI H[RSWKDOPRV LV SUHVHQW
o 7K\URLG VWRUP PDUNHG WDFK\FDUGLD GHOLULXP IHYHU
[ 299 ]
